Hemostatic bone putty

Ended Purchase Order Awarded Last action

Contract number
W81K0224P0005
Awardee
Awarding agency
Obligated
$50,000

Award facts

Opportunity
  • W81K0224Q0014 Solicitation number
Contract value 100% obligated
$50,000.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
Funding agency
Defense Health Agency Department of Defense
NAICS code
339113 Surgical Appliance and Supplies Manufacturing
PSC
6515 Medical And Surgical Instruments, Equipment, And Supplies
Set-aside
No set-aside
Competition
1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Stamford, CT 06902, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Health Agency awarded a $50,000 firm fixed price purchase order to Abyrx Inc. for hemostatic bone putty, effective November 10, 2023, with an ultimate completion date of August 31, 2024. This contract was performed at Abyrx's facility in Stamford, Connecticut, and was not designated as a set-aside procurement. Hemostatic bone putty is a biosurgical product used to control bleeding and promote bone healing in surgical procedures, aligning with the Defense Health Agency's mission to support medical readiness and patient care across the Military Health System.

Abyrx Inc., a manufacturer of surgical therapeutic devices and biosurgical products, has established itself as a reliable supplier to the Defense Health Agency and Department of the Army Medical Command since its registration to receive federal awards in 2013. The company's leadership comprises physicians, Ph.D.'s, and business leaders focused on delivering safe and effective surgical solutions. This award represents part of Abyrx's ongoing provision of proprietary medical devices and orthopedic surgical products to support the healthcare needs of U.S. military personnel and facilities, consistent with the company's historical contract performance with these agencies.

Quick answers

Who was awarded contract W81K0224P0005?

W81K0224P0005 was awarded to Abyrx Inc. by Medical Command (Department of the Army) on November 10, 2023.

How much is contract W81K0224P0005 worth?

The government has obligated $50,000 on W81K0224P0005.

Which agency awarded contract W81K0224P0005?

Medical Command (Department of the Army) awarded W81K0224P0005, with funding from Defense Health Agency (Department of Defense).

Was contract W81K0224P0005 competed?

The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award